Maharashtra Food and Drugs Administration (FDA) said it's working to bring down the cost of Remdesivir 100 mg injection, used for treating critical COVID-19 patients. "Manufacturers are supplying this injection at a cheaper cost of ₹800 to ₹1300 due to comparatively lesser demands than the initial days. But patients are not getting the benefit of the cheaper prices," FDA added.